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Background: Various treatments for unicameral bone cyst have been proposed. Recent concern focuses on the
effectiveness of closed methods. This study evaluated the effectiveness of demineralized bone matrix as a graft
material after intramedullary decompression for the treatment of unicameral bone cysts.
Methods: Between October 2008 and June 2010, twenty-five patients with a unicameral bone cyst were treated
with intramedullary decompression followed by grafting of demineralized bone matrix. There were 21 males and 4
female patients with mean age of 11.1 years (range, 3–19 years). The proximal metaphysis of the humerus was
affected in 12 patients, the proximal femur in five, the calcaneum in three, the distal femur in two, the tibia in two,
and the radius in one. There were 17 active cysts and 8 latent cysts. Radiologic change was evaluated according to
a modified Neer classification. Time to healing was defined as the period required achieving cortical thickening on
the anteroposterior and lateral plain radiographs, as well as consolidation of the cyst. The patients were followed
up for mean period of 23.9 months (range, 15–36 months).
Results: Nineteen of 25 cysts had completely consolidated after a single procedure. The mean time to healing was
6.6 months (range, 3–12 months). Four had incomplete healing radiographically but had no clinical symptom with
enough cortical thickness to prevent fracture. None of these four cysts needed a second intervention until the last
follow-up. Two of 25 patients required a second intervention because of cyst recurrence. All of the two had a
radiographical healing of cyst after mean of 10 additional months of follow-up.
Conclusions: A minimal invasive technique including the injection of DBM could serve as an excellent treatment
method for unicameral bone cysts.Background
Unicameral bone cysts (UBC) are benign fluid-
containing lesions lined by a thin membrane. They are
found in the metaphysis of long bones with the most
common site being the proximal humerus followed by
the proximal femur even though they may be found in
the calcaneus and pelvis. UBCs occur usually in the first
two decades of life. Those cysts that abut a physis are
termed active and those separated from the physis are
called inactive cysts. UBC may cause repetitive patho-
logical fracture and skeletal deformities during growth* Correspondence: ihpark@knu.ac.kr
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reproduction in any medium, provided the orbecause of its proximity to the physis. Surgical proce-
dures for the management have ranged from simple cur-
ettage with bone graft [1] to subperiosteal resection [2].
However, considering that the aim of treatment of UBC
is the prevention of fracture and skeletal deformity asso-
ciated with repeated fractures, aggressive open proce-
dures are not justified any more [3-8].
Since the intralesional steroid injection was introduced
by Scaglietti in 1974 [9], many percutaneous or minimal
invasive procedures have been proposed [10,11]. How-
ever, the success rate of percutaneous procedures has
been reported to vary [3,12]. Recent studies focus on the
effectiveness of percutaneous procedures in terms of re-
currence rate and the number of procedures. The basic
concept of closed method is decompression of cyst fol-
lowed by grafting of osteogenic materials. Many authors. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Modified Neer classification of radiological
results
Classification Description
Healed Cyst filled by new bone, with or without small
radiolucent area(s) < 1 cm in size
Healing with
defects
Radiolucent area(s) < 50% of the diameter of bone,
with enough cortical thickness to prevent fracture
Persistent cyst Radiolucent area > 50% of diameter of the bone and
with a thin cortical rim. No increase in the size of the
cyst. Continued restriction of activity or repeated
treatment is required
Recurrent cyst Cyst reappeared in a previously obliterated area, or a
residual radiolucent area has increased in size
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lized bone matrix (DBM) has recently served as a bone
substitute in many orthopedic fields and favorable
results were reported [7,13,14].
The purpose of this study was to evaluate the effect-
iveness of DBM as a graft material after intramedullary
decompression for the treatment of unicameral bone
cysts in terms of the overall success rate, recurrence and
the time to healing.
Methods
Between October 2008 and June 2010, twenty-five
patients who were diagnosed with unicameral bone cyst
were enrolled in this study. There were 21 boys and 4
girls, with a mean age of 11.4 years (range, 3–19 years).
The mean follow-up period was 23.9 months (range,
15–36 months). The proximal metaphysis of the hu-
merus was affected in 12 patients (48%), the proximal
femur in five (20%), the calcaneum in three (12%), the
distal femur in two (8%), the tibia in two (8%), and the
radius in one (4%). There were 17 active cysts and 8 la-
tent cysts. In all patients, the diagnosis was made after
radiographic workup for pain with activities of daily liv-
ing or secondary to a pathologic fracture. Eight patients
(32%) had experienced more than one pathologic frac-
ture before being admitted to our clinic. For the patients
with recent pathologic fracture, management for UBC
was postponed at least 3 months because obliteration of
cyst after healing of fracture may occur although it is
not the rule. In this study, all fractures were managed
conservatively and no patient achieved obliteration of
cyst after healing of fracture.
All procedures were performed by the senior authors
(IH Park, DS Shin) under general anesthesia and guided
by fluoroscopy. A less than 2-centimeter-skin incision
was made over the thinnest accessible wall of the cyst
avoiding neurovascular structures. A cortical window
was created to allow sweeping movement of curettes and
moving along the cyst lining. A sample tissue was sent to
histopathological analysis; diagnosis of UBC was con-
firmed in all patients. The content of the cyst was aspi-
rated and intramedullary decompression was performed
with a curette. Any septa within the cysts were also
removed by curettes. After washing out the cyst with
normal saline, gel-type DBM (ExFuse™, Hansbiomed Inc,
Seoul, Korea) was injected. The volume of the DBM was
determined by the size of the cyst, as measured on the
radiographs, using the formula (length ×width × height ×
π/6) [15]. The mean volume injected was 12 milliliters
(range, 5–25 milliliters). The wound was closed at least
10 minutes after injection of DBM to consolidate and
minimize the leakage of DBM. No metallic implant was
employed for stability in any patient. All patients were
discharged the day after surgery.Physical activity was restricted for four weeks in
patients with a lesion in the upper extremity and six
weeks in those with a lesion in the lower extremity.
Radiographs were taken every month after the procedure
for three months after surgery and repeated every three
months until evidence of healing was observed. Radio-
logic change was evaluated by three musculoskeletal
radiologists according to a modified Neer classification
[1] (Table 1). Time to healing was defined as the period
required achieving cortical thickening on the anteropos-
terior and lateral plain radiographs, as well as consolida-
tion of the cyst. Interobserver agreement was determined
by Fleiss’ kappa test [16], which is a statistical measure
for assessing the reliability of agreement between more
than 2 observers. This study was approved by the institu-
tional review board at Kyungpook national university
hospital (KNUHMD_07-0005). All patients included in
this study were informed that their cases would be sub-
mitted for publication, and consented.Results
The details of the 25 patients are given in Table 2.
The permanent pathology report confirmed all cysts as
UBC. At 4–6 weeks postoperatively, all patients were
pain free and had full range of motion of the adjacent
joint. Full activity including weight-bearing was resumed
within this time in all patients. At the last follow-up, all
patients were asymptomatic. Radiographical cyst healing
in terms of cortical remodeling was seen at a mean of
6.6 month follow-up (range, 3–12 months) (Figure 1).
Fleiss’ kappa value on rating of the modified Neer classi-
cation was 0.763. Two patients required a second inter-
vention because of cyst recurrence. The mean interval
from initial intervention to a second was 9.0 months
(range, 4–14 months). Both recurrences were active
cysts located in the proximal humerus and proximal
femur. Both patients had a radiographical healing of cyst
after mean of 10 additional months of follow-up. Four of
the 25 patients had incomplete healing radiographically
Table 2 Details of patients
No. Gender Age
(yrs)





1 M 5 Proximal femur Active 39 × 31× 29 Yes 3 Recurrent cyst*
2 M 12 Calcaneus Latent 20 × 20× 29 No 4 Healed
3 M 12 Distal femur Active 25 × 16× 25 No 4 Healed
4 M 6 Proximal humerus Active 72 × 26× 20 No 4 Healed
5 M 16 Proximal humerus Latent 69 × 30× 25 Yes 8 Healed
6 M 13 Proximal humerus Active 39 × 20× 20 Yes 6 Healed
7 F 12 Proximal humerus Active 18 × 15× 20 No 8 Healed
8 M 10 Proximal humerus Active 37 × 16× 15 No 6 Healed
9 M 14 Proximal humerus Latent 35 × 27× 25 Yes 10 Healed
10 F 10 Proximal humerus Active 60 × 18× 16 No 6 Healed
11 M 10 Proximal humerus Active 70 × 25× 25 No 6 Healed
12 F 10 Distal femur Active 75 × 30× 23 No 6 Healed
13 M 7 Distal radius Active 11 × 12× 9 Yes 8 Healing with defect
14 M 12 Proximal humerus Active 25 × 28× 20 Yes 12 Healed
15 M 10 Proximal humerus Active 36 × 17× 15 No 8 Healing with defect
16 M 3 Proximal humerus Active 35 × 17× 28 Yes 3 Recurrent cyst*
17 M 11 Proximal femur Active 35 × 20× 20 No 10 Healing with defect
18 M 19 Proximal femur Latent 60 × 25× 25 No 10 Healed
19 M 8 Distal tibia Latent 18 × 14× 14 No 6 Healing with defect
20 M 18 Proximal femur Active 50 × 15× 20 Yes 9 Healed
21 M 13 Proximal femur Active 25 × 20× 13 No 6 Healed
22 M 18 Middle humerus Active 36 × 15× 13 No 7 Healed
23 M 8 Calcaneus Latent 18 × 18× 15 No 4 Healed
24 M 10 Calcaneus Latent 18 × 13× 15 No 5 Healed
25 F 11 Proximal tibia Latent 40 × 13× 15 No 7 Healed
* It was difficult to define time to healing for recurrent cases. Consolidation of DBM within cyst was considered as initial time to healing regardless persistent cyst.
Figure 1 Radiographical cyst healing after injection of DBM.
Plain radiographs A) of the right humerus before surgery in a
13-year-old boy with cystic lesion located at the proximal
meta-diaphysis B) at postoperative 24 months.
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original cyst but had enough cortical thickness to pre-
vent fracture. None of four patients needed second
intervention until the last follow-up (Figure 2).
Extraosseous mineralization owing to leakage of DBM
was found in 2 patients, no additional surgery was ne-
cessary associated to DBM leakage. The leakage DBM
completely resorbed within 3 months in both cases
(Figure 3). There were no other significant complications
related to the procedure, nor did any fracture occur after
initiation of the above regimen.
Discussion
Although there is no standardized treatment for UBC, the
goal of treatment is to prevent pathological fracture and
skeletal deformities during growth associated to repeated
pathological fractures [3]. A painful lesion with precar-
ious cortical thinning demands surgical intervention,
Figure 2 Serial diagrams of final result of 25 cysts..
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cal procedures include injection of corticosteroid
[12,17,18] or bone marrow [11,18], decompression with
cannulated screw(s) [6], intramedullary nailing [19,20]
and open curettage followed by bone grafting [21-23]. In
this study, we evaluated the effectiveness of DBM as a
graft material in UBC treatment in terms of overall heal-
ing rate, recurrence, time to healing and associated com-
plication. In the present study, the healing rate with a
single intervention was 92% (23/25) and it reached 100%
after a second procedure.Figure 3 Leakage of DBM. Plain radiographs A) of the distal femur in a 1
(arrow) C) at the postoperative 13 months showing complete resorption oTo explain the etiology of UBC, several theories have
been proposed including a true intra-osseous synovial
cyst [24], the degenerative phase of a benign tumor [25],
failure to resorb hematomas [26], low-grade form of
osteomyelitis [27], and venous obstruction [28]. Of these
theories, venous obstruction has been suggested as being
the most probable cause of UBC. Considering that ven-
ous obstruction model is preferred, decompression of
cyst and injection of steroid or osteogenic materials has
replaced aggressive open procedure and bone grafting
[3,7,8]. There have been many reports on minimal0-year-old girl B) at postoperative one month showing leakage of DBM
f extraosseous DBM.
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[12,17,18,29]. Scaglietti [9] first described the percutan-
eous injection of methylprednisolone acetate as a treat-
ment of UBC in 1974. Subsequently, many authors have
reported satisfactory result with high success rates ran-
ging from 50% to 90% [21,22,29,30] Simplicity and low
morbidity associated with steroid injection made it popu-
lar. However, usually several procedures are necessary to
achieve consolidation of the cyst. The classic report by
Scaglietti using percutaneous steroid injection showed
only 24% healing rate after a single injection [18]. Many
other studies also suggested that close radiological sur-
veillance should be maintained and repeated steroid
injections may be needed to achieve adequate consolida-
tion [12,17,18]. Steroid injection might inhibit produc-
tion of bone resorptive factors by its anti-inflammatory
effect. In addition, it reduces internal pressure of cyst
through trepanation. However, steroid injection does not
provide bone-forming potential in itself.
Since autologous bone marrow grafting for UBC treat-
ment was introduced by Lokiec in 1996 [31], the injec-
tion of bone marrow alone or in combination with DBM
has been proposed as an alternative to steroid injection.
The injection of bone marrow provides osteoprogenitor
cells and DBM could stimulate new bone formation
owing to its osteoinductive and osteoconductive proper-
ties [5,14,32]. Recently, many authors have evaluated the
effectiveness of DBM as a graft substitute and it is ap-
plied in many surgical grafting procedures including
spinal fusion, joint reconstructive surgery, trauma and
oral/maxillofacial surgery. With respect to the use of
DBM in UBC treatment, the effectiveness as a graft ma-
terial after intramedullary decompression has been evalu-
ated by some authors [7,10,11,29,33] Kanellopoulos et al
[13] and Rougraff et al [14] reported about 90% success
rate after a single procedure using a mixture of DBM and
autologous bone marrow and it took six to nine months
to achieve cortical remodeling radiographically. In theFigure 4 Insufficient DBM in quantity leaded to inadequate healing o
3-year-old boy B) at postoperative 3 months showing filling defect of DBM
repeat intervention E) at 13 additional months of follow-up after a secondpresent study, we had a cumulative success rate of 100%.
In addition, the mean time to healing was 6.6 months. In
the current study, two cysts required a repeat procedure.
In both cases, the amount of DBM injected was not
enough to fill the entire cyst (Figure 4). The basic con-
cept of percutaneous procedure is the intramedullary de-
compression followed by grafting of osteogenic materials.
The importance of induction of osteogenesis following
intramedullary decompression in UBC treatment has
been advocated by several authors. The high recurrence
rate of steroid injection was probably caused by absence
of osteogenic potential. In this regard, DBM could be a
good grafting substitute for UBC treatment after intra-
medullary decompression owing to its excellent osteo-
genic property. In addition, it would be desirable to use
an adequate amount of DBM to fill the entire cyst. In the
case of Figure 3, it seemed that the insufficient DBM in
quantity led to inadequate healing of the cyst and eventu-
ally cyst recurrence.
ExFuse™ (Hansbiomed Inc, Seoul, Korea) used in the
current study is a mixture of carboxyl methyl cellulose
carrier and DBM extracted from freeze-dried allograft
with preserving its osteoinductive and osteoconductive
properties.
In the present study, we made a small skin incision
and created a cortical window over the thinnest access-
ible wall of the cyst. This made it possible to allow pas-
sage and sweeping movement of curettes and made it
easy to decompress the intramedullary pressure, remove
the cyst lining and get biopsy material. Even though our
procedure may seem to be a more aggressive than other
percutaneous procedures, the high success rate in the
present study may be attributed to more aggressive re-
moval of cyst lining and intramedullary decompression
through a cortical window Killian [8]. Another advantage
of making a cortical window includes obtaining the bi-
opsy material. Some malignant lesions such as Ewing’s
sarcoma or osteosarcoma may show cystic featuresf the cyst. Plain radiographs A) of the proximal humerus in a
C) at postoperative 14 month showing recurrence of cyst D) after
intervention.
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ial is important to confirm the diagnosis of UBC.
Our study has several limitations. First, we could not
perform any sound analysis to find associated prognostic
factors for persistent cyst or recurrence because the
number of patients enrolled was relatively small. How-
ever, the recurrence rate of the cyst was low (8%) even
though this study included many active cysts in younger
patients, which are known to be aggressive and resistant
to treatment [19,36]. Another limitation of our study is
the absence of a comparative group or randomized com-
parison. In future study, large scale and long-term
follow-up clinical studies are required.
Conclusions
Minimal invasive technique followed by DBM grafting
could serve as an excellent treatment method for UBC.
The method offers low morbidity, a short hospital stay,
and a high success rate. In addition, the advantage of
making a small cortical window allows easy decompres-
sion of cyst, complete removal of cyst lining and obtain-
ing biopsy material.
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